NCT06828406 · Endeavor Health
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
(I'M SPEAKING)
What this study is about
To evaluate the effectiveness of an existing quality improvement (QI) training program known as TeamBirth, using a randomly assigned stepped-wedge hybrid type II study design, to (a) decrease nulliparous term singleton vertex (NTSV) cesarean birth (CB) across all birthing people, and specifically for Black birthing people, and (b) increase shared decision-making (SDM), (c) improve patient experience of respectful care. TeamBirth uses a train-the-trainer model to implement patient-participatory shared decision-making on Labor and Delivery (L\&D) units, with the goal of decreasing unwanted and unnecessary interventions and improving patient experiences and outcomes for labor and birth.
View original scientific description
To evaluate the effectiveness of an existing quality improvement (QI) training program known as TeamBirth, using a randomized stepped-wedge hybrid type II study design, to (a) decrease nulliparous term singleton vertex (NTSV) cesarean birth (CB) across all birthing people, and specifically for Black birthing people, and (b) increase shared decision-making (SDM), (c) improve patient experience of respectful care. TeamBirth uses a train-the-trainer model to implement patient-participatory shared decision-making on Labor and Delivery (L\&D) units, with the goal of decreasing unwanted and unnecessary interventions and improving patient experiences and outcomes for labor and birth.
Interventions
BEHAVIORAL
TeamBirth
TeamBirth
Primary outcome measures
Nulliparous Term Singleton Vertex (NTSV) Cesarean Birth (CB)
Time frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
NTSV CB Rate for all birthing people in participating hospitals
Shared Decision Making (SDM)
Time frame: 6 months prior to TeamBirth, 3 months post TeamBirth implementation
Childbirth Options, Information, and Person-Centered Explanation (CHOICEs) scale, scores range from 14 to 90, high scores indicate higher levels of shared decision making
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Age 18 or older
- English or Spanish speaking
- Gave birth to a live-born infant after laboring
Exclusion criteria
- Speaks a language other than English or Spanish
- Under the age of 18
- Gave birth to a nonliving infant
- Cesarean delivery without labor
Where
- Arlington Heights, Illinois
- Aurora, Illinois
- Berwyn, Illinois
- Carbondale, Illinois
- Chicago, Illinois
- Elmhurst, Illinois
- Evanston, Illinois
- Highland Park, Illinois
- Hinsdale, Illinois
- Hoffman Estates, Illinois
- Kankakee, Illinois
- Lake Forest, Illinois
And 3 more locations — see the full list below.
Collaborators
University of Illinois at Chicago, University of Chicago, Ariadne Labs, University of Michigan, Northwestern University, Patient-Centered Outcomes Research Institute
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jul 15, 2026 · Source of record for eligibility and locations